Financials LUMIBIRD

Equities

LBIRD

FR0000038242

Advanced Medical Equipment & Technology

Market Closed - Euronext Paris Other stock markets 11:35:06 2024-05-31 am EDT			5-day change	1st Jan Change
12.85 ^EUR	-.--%		-4.81%	+5.50%

May. 23	Lumibird: strategic plan confirms objectives	CF
May. 03	Lumibird launches product for dry eyes	CF

Valuation

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Capitalization ¹	279.8	312.6	533.7	369.9	269.6	283.7	-	-
Enterprise Value (EV) ¹	261.6	320.6	548.6	422.4	358.5	356.5	337.2	308.9
P/E ratio	29.2 x	46.8 x	38.8 x	32.5 x	-	19.2 x	14.4 x	11.4 x
Yield	-	-	-	-	-	-	-	-
Capitalization / Revenue	2.54 x	2.47 x	3.28 x	1.94 x	1.32 x	1.27 x	1.16 x	1.09 x
EV / Revenue	2.38 x	2.53 x	3.38 x	2.21 x	1.76 x	1.59 x	1.38 x	1.19 x
EV / EBITDA	12.5 x	13.5 x	16.8 x	13.5 x	9.93 x	8.59 x	6.84 x	5.39 x
EV / FCF	29.1 x	429 x	65.3 x	-21.9 x	-76.3 x	32.1 x	17 x	10.7 x
FCF Yield	3.43%	0.23%	1.53%	-4.57%	-1.31%	3.11%	5.89%	9.39%
Price to Book	2.24 x	1.93 x	3.25 x	1.91 x	-	1.37 x	1.25 x	1.13 x
Nbr of stocks (in thousands)	18,409	22,268	22,191	22,339	22,134	22,080	-	-
Reference price ²	15.20	14.04	24.05	16.56	12.18	12.85	12.85	12.85
Announcement Date	3/31/20	3/16/21	3/17/22	3/14/23	3/12/24	-	-	-

¹EUR in Million²EUR

Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Net sales ¹	110.1	126.7	162.5	191	203.6	223.6	244	260
EBITDA ¹	20.97	23.7	32.6	31.3	36.1	41.5	49.3	57.3
EBIT ¹	12.26	14.1	19.8	16.4	20.9	23.8	30.25	36.9
Operating Margin	11.14%	11.13%	12.18%	8.59%	10.27%	10.64%	12.4%	14.19%
Earnings before Tax (EBT) ¹	10.57	7.2	17.6	14.4	7.5	19.6	25.9	32.5
Net income ¹	8.82	5.6	13.9	11.4	7.1	15	20	25.2
Net margin	8.01%	4.42%	8.55%	5.97%	3.49%	6.71%	8.2%	9.69%
EPS ²	0.5200	0.3000	0.6200	0.5100	-	0.6700	0.8900	1.125
Free Cash Flow ¹	8.975	0.747	8.4	-19.3	-4.7	11.1	19.85	29
FCF margin	8.15%	0.59%	5.17%	-10.1%	-2.31%	4.96%	8.14%	11.15%
FCF Conversion (EBITDA)	42.79%	3.15%	25.77%	-	-	26.75%	40.26%	50.61%
FCF Conversion (Net income)	101.76%	13.34%	60.43%	-	-	74%	99.25%	115.08%
Dividend per Share	-	-	-	-	-	-	-	-
Announcement Date	3/31/20	3/16/21	3/17/22	3/14/23	3/12/24	-	-	-

¹EUR in Million²EUR

Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December	2020 S1	2021 S1	2022 Q2	2022 S1
Net sales ¹	46.2	75.5	46	84
EBITDA	-	-	-	11.2
EBIT	-	-	-	2.5
Operating Margin	-	-	-	2.98%
Earnings before Tax (EBT)	-	-	-	-
Net income	-	-	-	-
Net margin	-	-	-	-
EPS	-	-	-	-
Dividend per Share	-	-	-	-
Announcement Date	7/27/20	7/26/21	9/22/22	9/22/22

¹EUR in Million

Estimates

Balance Sheet Analysis

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Net Debt ¹	-	8	14.9	52.5	88.9	72.8	53.5	25.2
Net Cash position ¹	18.2	-	-	-	-	-	-	-
Leverage (Debt/EBITDA)	-	0.3376 x	0.4571 x	1.677 x	2.463 x	1.753 x	1.084 x	0.4398 x
Free Cash Flow ¹	8.98	0.75	8.4	-19.3	-4.7	11.1	19.9	29
ROE (net income / shareholders' equity)	8.18%	3.88%	8.02%	6.08%	3.69%	7.3%	8.95%	10.2%
ROA (Net income/ Total Assets)	-	-	-	3.17%	1.83%	3.7%	4.8%	5.7%
Assets ¹	-	-	-	359.8	387.2	405.4	416.7	442.1
Book Value Per Share ²	6.780	7.290	7.390	8.680	-	9.400	10.30	11.40
Cash Flow per Share ²	1.190	0.8600	1.180	1.360	-	1.500	1.800	2.000
Capex ¹	11.3	12.3	18.2	20.7	25.3	19.3	16.3	15.8
Capex / Sales	10.25%	9.71%	11.2%	10.84%	12.43%	8.61%	6.66%	6.08%
Announcement Date	3/31/20	3/16/21	3/17/22	3/14/23	3/12/24	-	-	-

¹EUR in Million²EUR

Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Ratings for LUMIBIRD

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

12.85 EUR

Average target price

17.75 EUR

Spread / Average Target

+38.13%

Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
LUMIBIRD	+5.50%	308M
THERMO FISHER SCIENTIFIC	+7.01%	217B
DANAHER CORPORATION	+11.01%	190B
INTUITIVE SURGICAL, INC.	+19.20%	143B
BOSTON SCIENTIFIC CORPORATION	+30.79%	111B
SIEMENS HEALTHINEERS AG	+1.48%	64.59B
EDWARDS LIFESCIENCES CORPORATION	+13.95%	52.36B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-0.16%	48.45B
AGILENT TECHNOLOGIES, INC.	-6.20%	38.03B
GE HEALTHCARE TECHNOLOGIES INC.	+0.91%	35.6B

Other Advanced Medical Equipment & Technology